Evidence map›Paper›PMID 31300504›Full record

ArticleBMJ open2019

External validation of the quick Sequential Organ Failure Assessment score for mortality and bacteraemia risk evaluation in Japanese patients undergoing haemodialysis: a retrospective multicentre cohort study.

Hiroki Nishiwaki, Sho Sasaki, Takeshi Hasegawa, Fumihiko Sasai, Hiroo Kawarazaki, Shun Minatoguchi, Daisuke Uchida, Kenichiro Koitabashi, Takaya Ozeki, Fumihiko Koiwa and 1 more

Open access · goldAbstract readMulticenter Study
In one paragraph

Article in BMJ open, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
0.3field-weighted citation impact, top 38% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 5 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Carbapenem-resistant IMP-1-producing Pseudocitrobacter vendiensis emerging in a hemodialysis unit.Brazilian journal of microbiology : [publication of the Brazilian Society for Microbiology] · 2022
    Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 7 institutions in 1 country.

Hiroki NishiwakiDivision of Nephrology, Department of Medicine, Showa University Fujigaoka Hospital, Yokohama, Japan.ORCID 0000-0001-7365-7685
Sho SasakiCenter for Innovative Research for Communities and Clinical Excellence, Fukushima Medical University, Fukushima, Japan.
Takeshi HasegawaDivision of Nephrology, Department of Medicine, Showa University Fujigaoka Hospital, Yokohama, Japan.
Fumihiko SasaiDivision of Nephrology, Department of Medicine, Showa University Fujigaoka Hospital, Yokohama, Japan.
Hiroo KawarazakiDepartment of Nephrology, Inagi Municipal Hospital, Inagi, Japan.
Shun MinatoguchiDepartment of Nephrology, Chubu Rosai Hospital, Nagoya, Japan.
Daisuke UchidaDepartment of Nephrology and Hypertension, Kawasaki Municipal Tama Hospital, Kawasaki, Japan.
Kenichiro KoitabashiDivision of Nephrology and Hypertension, Saint Marianna University School of Medicine, Kawasaki, Japan.
Takaya OzekiDepartment of Nephrology, Nagoya University Graduate School of Medicine, Nagoya, Japan.
Fumihiko KoiwaDivision of Nephrology, Department of Medicine, Showa University Fujigaoka Hospital, Yokohama, Japan.
JOINT-KD collaborators
Showa University · JPShowa University Fujigaoka Hospital · JPChubu Rosai Hospital · JPFukushima Medical University · JPKawasaki Municipal Hospital · JPSt. Marianna University School of Medicine · JPToyohashi Municipal Hospital · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectivesWe aimed to examine the validity of the quick Sequential Organ Failure Assessment (qSOFA) score for mortality and bacteraemia risk assessment in Japanese haemodialysis patients.

designThis is a retrospective multicentre cohort study.

settingThe six participating hospitals are tertiary-care institutions that receive patients on an emergency basis and provide primary, secondary and tertiary care. The other participating hospital is a secondary-care institution that receives patients on an emergency basis and provides both primary and secondary care.

participantsThis study included haemodialysis outpatients admitted for bacteraemia suspicion, who had blood drawn for cultures within 48 hours of their initial admission. PRIMARY AND SECONDARY OUTCOME MEASURES: The primary outcome measure was overall in-hospital mortality. Secondary outcomes included 28-day in-hospital mortality and the incidence of bacteraemia diagnosed based on blood culture findings. The discrimination, calibration and test performance of the qSOFA score were assessed. Missing data were handled using multiple imputation.

resultsAmong the 507 haemodialysis patients admitted with bacteraemia suspicion between August 2011 and July 2013, the overall in-hospital mortality was 14.6% (74/507), the 28-day in-hospital mortality was 11.1% (56/507) and the incidence of bacteraemia, defined as a positive blood culture, was 13.4% (68/507). For predicting in-hospital mortality among haemodialysis patients, the area under the receiver operating characteristic curve was 0.61 (95% CI 0.56-0.67) for a qSOFA score ≥2. The Hosmer-Lemeshow χ

conclusionOn external validation, the qSOFA score exhibited low diagnostic accuracy and miscalibration for in-hospital mortality and bacteraemia among haemodialysis patients.

Indexed as

Organ Dysfunction ScoresAgedAged, 80 and overBacteremiaFemaleHospital MortalityHumansIncidenceJapanMaleRenal DialysisRetrospective StudiesRisk Assessmentdialysisinfectious diseasesnephrology

Identifiers

PMID31300504
PMCPMC6629386
OpenAlexW2959124617

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.